NAPRX/CNPR Exam Questions With 100% Correct And Verified Answers | Latest Update, Exams of Advanced Education

Download NAPRX/CNPR Exam Questions With 100% Correct And Verified Answers | Latest Update and more Exams Advanced Education in PDF only on Docsity!

NAPRX/CNPR Exam Questions With 100%

Correct And Verified Answers | Latest Update

1. Howiareidrugsisortediintoitherapeuticigroupsiandiclasses? firstibyitheiconditionsithatitheyiareiuseditoitreat.iandithenibyitheirimechanismsiofiaction
2. Boneimarrowitransplants. areiaitypeiofistemicellitherapy.iunlessipatient'siownicellsiareireinjected.
3. WhatidoesiAMAis tandifor?iAmericani MedicaliAssociation
4. Whatisectioniofiaidrug'sipackageiinsertidescribesisituationsiiniwhichitheidrugish ouldinotibeiusedbecauseitheirisksioutweighitheitherapeuticibenefits? contraindications 5 iWhatiisitertiaryicare? highlyispecializedimedicaliandisurgicalicareiprovidedibyiailargeimedicalicenteriforiunu sualioricomplexmedicaliproblems 6.iWhichiofitheifollowingiisiNOTioneiofitheistagesiinitheiclassiciapproachitoibrandideve lopmentistrategycoverediiniyourimanual? brandiquality 7 iWhatiareivasodilatorsiuseditoido? decreaseivasculariresistanceiandiincreaseibloodiflow
5. Whatiisitheinameiofitheiconditionithatioccursiafteriaispecificidoseiofiaidrugiisigive niatisuchiregulariintervalsithatiabsorptioniandieliminationi(andithereforeidrugiplasma iconcentration)ihaveibecomeifairlyconstant? SteadyiState
6. WhichistatementiisiTRUEiaboutioculariadm inistration?iOculariadministrationiisiusediprim

arilyitoitreatitheieye.

10. Whichientitiesiinvest'sitheimostimoneyiinipharmaceuticaliR&D? U.S.ipharmaceuticalicompanies

11. Howiareimostidrugsie xcreted?iviaitheikidneys
12. Overitheilastifewidecades,iwhatihasihappeneditoilegalilimitationsionisales'irepsidis cussionsiaboutioflabeliuses? Limitationsihaveidecreased.

14.iWhatidoesiitimeaniifitwoidrugsiareiat iparity?iBothidrugsiareiessentiallyiiniain eutraliposition. 15 iWhoiisimostilikelyitoibenefitifromielectronicisamplingiprograms?i Everyoneiwouldibenefitiequallyifromielectronicisamplingiprograms 16.iWhenireferringitoimedicationidosage,iwhichiabbreviationimeansi" one-half'SS 17 iWhatiisianiinternist? aiphysicianiwhoipracticesiinternalimedicine

18. Whichiofitheifollowingiisiaitypeiofiwhiteibl oodicell?iLymphocytes
19. WhyiareinoviceisalesirepresentativesiofteniplacediinichargeiofinegotiatingiM COiformularies?iTheyiareinot.iThisijobiisiusuallyireservediforimoreiexperienc edireps.
20. Whatidistinguishesipharmacodynamicsifromiph armacokinetics?iPharmacodynamicsistudiesitheiho witheibodyiafectsidrugs. 21 iWhatiproportioniofitheidrugsitestedionihumanisubjectsiareieventuallyiapprovedib yitheiFDA?iabouti70%
21. Accordingitoiaistudyidiscussediiniyourimanual,ihowidoimostiphysiciansipreferitoi receiveitheiridrugsamples? directlyifromisalesirepresentatives
22. Whichiofitheifollowingiisianiexampleiofiaic entralivalue?iIibuyiAdvilitoishowithatiI'miaimo derniconsumer.

24. WhichiofitheifollowingispecialtiesilikelyihasitheiMOST

emergencyicalls?icardiologist

25. Whatiafectsitheirateiofiactiveitransport? neitheritheiavailabilityioficarriersinoritheiavailabilityiofienergy
26. Overitheilastifewidecades,iwhatihasihappeneditoitheiFDAiapprovalitim eiforinewidrugs?iItihasibeenishorteneditoireduceitheicostiofinewidrugidevelo pment.
27. WhichiofitheifollowingiwouldiNOTihelpiimproveico mpliance?ipharmacistsiunderstandingihowigenericsidif erifromibrandinameidrugs

28. Whichientityichoosesiaidrug'sit radeiname?itheiFDA
29. Whatitypeiofistemicellsiareiobtainedifromiembryosiandicanidevelopiint oianyicellitype?itotipotent
30. Asitheipriceiaipatientipaysiforiaiprescriptioniincreases,iwhatihappensitoitheilik elihoodithatithepatientiwillifilliit? Itiremainsiunafectedibecauseitheiprescriptioniisineeded
31. Mostiinvoluntaryimovementsicomeifromiwhichitypeiofi muscleitissue?icardiaciandismooth
32. WhichiofitheifollowingiisiNOTioneiofitheibody'simajorior ganisystems?itheicellularisystem
33. Howidoimostidrugsiexertitheiriprimaryiphysiol ogicaliefects?byibindingitoicellireceptorsithatiareis ensitiveitoitheiripresence
34. Whatiisitheimostireliableisourceiofiinformationiforideterminingith erapeuticallyiequivalentidrugproducts? OrangeiBook
35. Whatidoesisubcutaneousi mean?ibeneathitheiouteriskin
36. Whatishouldiaisalesirepresentativeidoiifialliofitheiprimeispacesiiniaidrugicab inetiareicoccupied?iaskistafiforipermissionitoimoveisomeiofitheiotheriproduct siinitheicabinet
37. Itiisiinappropriateiforiphysicians'iprescribingibehaviorsitoibeieducatedibyitheiripe rsonalitastesiandidiosyncrasies TRUE
38. TheiFDAidefinesiAPIiasitheiactiveiingredientiiniaidrug,iwhichiproducesitheide

siredichangeiinithebody. pharmaceutical

39. Whatiareithei 2 ilegaliclassificationsiofi wholesalers?primaryiandisecondaryiwho lesaleidistributors

40. WhatitermidescribesitheiusageiofiaimedicationiforipurposesiotherithanitheiFDA- iapprovediindicationsonitheilabeling? of-labeliusage
41. Whatiisitheiacronymifori pharmacokinetics?iPK
42. Theidosageirangeiofiaidrugithatiisibothisafeiandibeneficialiisiknowniasitheithe rapeuticiwindow.True
43. WhatiisitypicallyiNOTiaicharacteristiciofiaipharmace uticalisalesirep?iPharmaceuticalisalesirepsiareinoticoncer nediabouticompetitors.
44. Whatientityigrantsidrugi patents?iTheiUSiPatentiandi TrademarkiOffice
45. Whichiofitheifollowingirefersitoialliactiveiandiinertipharmaceuticaliin gredientsiiniaidrug,includingfillersiandicolors? formulation
46. Whatiisitheidiferenceibetweenipotencyiandiefficacy? potencyirefersitoitheidrug'sistrength,iwhileiefficacyirefersitoiitsiefectiveness
47. Whatiisitheiminimumileveliofieducationirequirediforiain urseipractitioner?iaigraduateidegree
48. Howimanyinamesimustiai drugihave?iatileastithree
49. Howihasiailongeridevelopmentitimeiincreaseditheicostiofibringingiaine widrugitoimarket?iIncreasingitheicostioficapital
50. Senioricitizensiconsumeioveritimesiasimanyipharmaceuticalsiasip eopleiunderi65.three

51. Whatiagencyiregulatesitheidistributioniandiuse

ofinarcotics?iDEA

52. Whatiisipassiveidifusion? wheniaisubstanceifreelyimovesithroughiaimembraneifromiaihighiconcentrationigradien titoiailowione
53. WhatiareitheiMAINicategoriesiofidrugsiunderiFDAijurisdiction?

prescriptioniandinoniprescription

55. Whatiareiallimetab olites?iproductsiofimet abolism
56. Wheniaidrugiisiadministerediorally,iwhereidoesifirst- passimetabolismioccur?iliver
57. Whatiisitheimedicalitermiforis welling?iedema
58. WhichiofitheifollowingiisiNOTipartiofitheiSeveniStepiC ascadeiofiEmotion?ibeiaiconsultant,inotiairep
59. Whichipartiofiaiclinicaliresearchipaperiisifrequentlyireferreditoiasi theiroadimap?iabstract
60. Whichiofitheifollowingiisiaimainiactiveiingredientiinilu ngisurfactants?itheophylline
61. Whatidoesiparenterali mean?iinjection
62. Whichitermidenotesiaitypeiofisubstanceithatienhancesitheiactioniofiaidr ugioriantigen?iadjunvant
63. Ifiaisalesirepresentative'siproductiisiplacedionitheiseconditieriofiaistandardithr ee-tieriformulary,iwhichiofitheifollowingiisimostilikelyitrue? Itiprobablyihasiexclusiveipreferredistatusiifiitiisinotiatiparityiwithianyiotheridrugs
64. WhichiofitheifollowingiisiNOTioneiofitheifouribasicitr ansportimechanisms?ihomeostasis
65. Whichistatementiaccuratelyidescribesiairelationshipibetweenidrugiago nistsiandiantagonists?iAgonistsiandiantagonistsicanibeiuseditogether.

66. Whatiisitheistudyiofitheiefectsiandimovementiofidrugsiinith eihumanibody?iclinicalipharmacology

67. Accordingitoiyourimanual,iwhatiisiaicommonicomplaintithatiphysiciansiha veiaboutitraditionalsamplingimethods? thatidrugisampleisupplyiisitooiunpredictable

68. Whichiofitheseientitiesiisiformedibyitwoiorimoreihospitalsioriotherihealthcareient itiesitoinegotiatereducediratesiwithiitsiaggregatedipurchasingipower? GPO
69. Whatiisianotherinameiforiaidrugiderivedifromiaibi ologicicompound?ilargeimolecule
70. Whatiisitheimosticommonipolicyiregardingipharmaceuticalirepsidi spensingidrugisamplesiinhospitals? drugisamplingiisiofteniforbidden 71 iWhichiofitheifollowingiwouldihelpiyouibuilditrustiwithiaiphysician? askingiifiheiorisheiisihavingianyiproblemsiwithitheimanagedicareicoverageiofiyouriprod ucts
71. Whatitermidenotesitheidiferenceibetweenitheiusualiefectiveidoseianditheido seithatiinducessevereiorilife-threateningisideiefects? marginiofisafety
72. Whatiareiexcipients? theiinertiingredientsiiniaidrugiformulation
73. Whatiisianotheritermiforithei AWP?listiprice
74. Whichiofitheseiisitheimostilikelyiuseiforiaiut erotoniciagent?itoiinduceilabor
75. AsiofiNovemberi2013,iwhichiofitheseicountriesihasilegalizediDTCiadvertisingiofi prescriptionidrugs?noneiofithese
76. Whyiareioralidrugsioftenitakenionianiempt yistomach?itoipassithroughitheistomachimorei quickly
77. Whatiisioneifactorithatidiferentiatesicommunityihealthicentersifr omihospitals?icommunityihealthicenteriformulariesiareimoreirestri

ctive

79. Howidoesidrugisamplingiprovideiaisocialibenefit? doctorsiofteniuseidrugisamplesitoitreatipatientsiwhoiotherwiseicouldinotiafordiit
80. Whichimedicalitermidenotesitheiuseiofiaistethoscopeitoili stenitoitheiheart?iausculation
81. Whatidoientericicoatingsido?

preventsidissolutioniinitheistomach

82. Whatiisitheidurationiofiexclusivityiforio rphanidrugs?i 7 iyears
83. WhatidoiNationaliAccountiMa nagersido?inegotiateicontractsiwit hiMCOiandiPBM
84. Whatidoesiitiusuallyimeaniifiaidrugirecalliisivoluntary? Theimanufacturerihasirecalleditheiproductioniitsiown.ibutinegotiatediwithitheiFDAibefo rehand.
85. Whichiphaseioficlinicalitrialsiisialsoiknowniasitheipi votaliphase?iPhaseiIII
86. Duringiwhichiphaseioficlinicalitrialsiisitheinewidrug'sisafetyiandief ectivenessifirstitestediinithetargetigroup? PhaseiII
87. Howidoiantacidsi work?byiraisingiga striciPH
88. Whatiisioneiofitheibiggestitimeiwastersiforiaip harmaceuticalisalesirep?iTraveliTime
89. Whatihappensiwheniequilibriumiisireached? equalinumbersiofimoleculesicrossitheimembraneiinibothidirections
90. Whatiareitheimosticommonivectorsiusediinig eneitherapy?iviruses
91. Whatiisitheipercentageifeeithatitheidispenseripaysitheiwholesalerifo ridistribution?iupcharge
92. Whatiisitheidiferenceibetweeniaichronici(oricontinuing)ireaction,iandiaide

layedireaction?ichronicireactionsipersistiforiailongitime,idelayed

reactionsitakeisomeitimeitoidevelopi 9 3 iWhatiisiclinicaliefect? theiresponseiproducedibyiaimedication

94. Whichiofitheifollowingiisianiexampleiofin oncompliance?iaipatientiforgettingitoitakeiaidr ugiatiaispecifieditimeiofiday
95. Whatiisitheiaverageicirculationitimeiofiblood?

aboutiaiminute

96. Whatiisioneiwayiiniwhichipharmaceuticalisellingiisidiferentifromisellingiinimo stiotheriindustries?irepresentativeidoiNOTisellitoitheiendiuseriofitheiproduct
97. Fromiwhatitypesiofientitiesidoiprimaryiwholesaleidistributorsibuyim ostiofitheiridrugs?manufacturers
98. WhatiisitheiOfficeiofitheiInspectori Generali(01G)?ianiarmiofitheiDeptiofi HealthiandiHumaniServices
99. Whatiareidoctorsirequireditoiconsideriwhenidecidingiwhetheriorinotitoiprescribei aiparticularidrug?itheiseverityiofitheidisorderibeingitreatedianditheiefectiitihasionithei patientsiqualityiofilife
100. Whichientityiassignsiainewidrugiitsigen ericinames?itheiUnitediStatesiAdoptediNam eiCouncil
101. Drugsicanibeiusedidaysibeyonditheirie xpirationidate.drugsinevericanibeiusedibe yondiexpirationidate
102. Whatiisinecessaryiforiaidrugitoibeiexcretediextensivelyiviaitheikidneys? Theidrugimustibeiwater-soluble,iandinotibinditooitightlyitoiproteiniinitheibloodstream
103. Whichiorganizationioriindividualiinitiatesitheiclinicalitrialiandifi nancesitheistudy?isponsor
104. Theinameidescribesitheiatomiciorimolecularis tructureiofiaidrug.chemical
105. UnderiPhRMAiCode,iisiitiacceptableioriunacceptableiforiaipharmaceuti calisalesirepitoitakeiaphysicianianditheiphysician'sispouseitoiaifundraisingidin

ner? neveri(unacceptable)

106. TheiHatch-WaxmaniActiisiconsidereditheimostisignificantidrug- relatediafectingitheipharmaceuticalindustryisincei1962. legislation
107. Whatitermidenotesitheitheiextent,iquality,ioridegreeitoiwhichiaisubstanceiisipoi sonousioriharmfultoitheibody? toxicity
108. WhatiissueihasiMOSTiencouragediconsumers'idesireitoiseeimoreiO TCimedications?ilackiofiinsuranceicoverage

109. Whatiisitheidegreeitoiwhichiaimedicationiproducesiaith erapeuticiefect?iefficacy
110. Whatiisitheimostiimportantibenefitiofielectronicip rescribing?isafety
111. WhenidoesitheiFDAiregulatei genericidrugs?ialways
112. Whichiphaseiofitrialsilargelyideterminesitheic linicalidose?iPhaseiIIitrials
113. Whatiisianiadvantageiofiinactivatedivaccinesioveriatten uatedivaccines?iinactiveivaccinesihaveiaimoreistableishelfili fe
114. Whichimedicalitermidenotesiailowisupplyiofioxygenidueitoilo wibloodiflow?iischemia
115. Whatiareitheitwoimainitypesiofiprescriptionidrugim arketing?iprofessionaliphysicianipromotionsiandidire ct-to-consumeriadvertising
116. Whatiisitheisiteiofideliveryiforisubcutaneousii njections?ifattyitissueibeneathitheisurfaceiofitheisk in
117. WhatimustibeicontainediinitheiDescriptionisectioniofiaipharmaceutical ipackageiinsert?itheiproprietaryinameianditheiestablishediname
118. Whatiisitheistudyiofiaimedication'siefectsiasiititravelsith roughitheibody?ipharmacokinetics
119. Customersipurchaseiproductsifromipeopleitheyilike,itrust,iandirespect.iT